France· FR:69985098
HEXASTAT, gélule
A altretamine product containing altrétamine, registered in France by LABORATOIRES DELBERT, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Altretamine is registered in 3 of 19 countries.
Countries holding a registration under ATC L01XX03 (altretamine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Altretamine · ATC L01XX03
3 / 19 countries
- Finlandprice
- Franceprice
- United Kingdom
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ALTRÉTAMINE
- Manufacturer
- LABORATOIRES DELBERT
- Country
- France (FR)
- ATC code
- L01XX03
- ATC class
- Altretamine
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
1 priced- cip133400932247400plaquette(s) thermoformée(s) aluminium PVC PVDC de 25 gélule(s)EUR 17.9
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
109 interactions on record for altretamine.
Graded by severity as the source publishes them — 30 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Altretamine · interactions on record
109 records
- 30 severe
- 64 moderate
- 15 minor
Most severe, free to view
- CladribineL01BB04severe
- Talimogene laherparepvecL01XL02severe
- Talimogen laherparepvecL01XX51severe
- LeflunomidL04AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Altretamine in 1 other country
What each register calls a product with the same active substance — salts and hydrates count as the same.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/92bc0817-0f26-488e-90eb-5c2f53f64058 GET /v1/drugs/92bc0817-0f26-488e-90eb-5c2f53f64058?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "69985098",
"date_amm": "1979-01-22",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "ALTRÉTAMINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "gélule",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about altretamine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.